期刊文献+

H5N1亚型禽流感病毒血凝素蛋白单链抗体基因的克隆及表达

Cloning and Expression of Single-Chain Fv Antibodies Against H5N1 Avian Influenza Virus Hemagglutinin
原文传递
导出
摘要 构建并表达H5N1亚型禽流感病毒血凝素蛋白单链抗体,为禽流感靶向治疗药物的研制制备靶向载体。从分泌血凝素单克隆抗体的杂交瘤细胞株中提取mRNA,采用RT-PCR法扩增出重链和轻链可变区基因,通过SOE-PCR法将重链和轻链通过Linker连接起来构建单链抗体基因,将获得的单链抗体基因装入原核表达载体pET28a(+)中,构建重组质粒并表达,以Western blot鉴定单链抗体的特异性。结果成功构建了单链抗体基因,全长714bp,经原核表达,所构建的单链抗体可与H5亚型禽流感病毒HA蛋白特异结合,为禽流感的靶向治疗奠定了基础。 To construct Fv antibodies against H5N1 Avian influenza virus hemagglutinin,extracted mRNA from B lymphoblastoid cell lines secreting anti-HA antibodies was used and the VH and VL genes were amplified by RT-PCR and linked together by splicing overlap extension (SOE) with (Gly4 Ser)3 linker. The recombinant plasmid was then transformed to E. coli BL21 (DE3) and sequence analysis indicated the total length of scFv was 714bp and the expression of Fv was validated by PAGE and Western blot.
出处 《病毒学报》 CAS CSCD 北大核心 2009年第1期63-67,共5页 Chinese Journal of Virology
基金 国家重点基础研究发展计划(973计划)课题(2005CB523005)
关键词 禽流感病毒 血凝素蛋白 单链抗体 克隆 表达 AIV hemagglutinin scFv cloning expression
  • 相关文献

参考文献8

  • 1傅生芳,独军政,常惠芸,陈怀涛.禽流感病毒的分子生物学研究进展[J].动物医学进展,2005,26(5):22-24. 被引量:18
  • 2WHO. Cumulative number of confirmed human cases of avianinfluenza A/(H5N1) reported to WHO:2007. http://www.who. int/csr/disease/avianinfluenza/country/cases table 2007 03 08/en/index. html.
  • 3Nicholson K G, Wood J M, Zambon M. Influenza[J]. Lancet,2003,362 (9397) :1733-17451.
  • 4侯小强,夏咸柱,高玉伟,王铁成,杨松涛,王承宇,黄耕.H5亚型虎源流感病毒血凝素单抗制备及胶体金试纸条的研制[J].动物医学进展,2007,28(1):22-25. 被引量:3
  • 5Colcher D,Bird R, Roselli M, et al. In vivo tumor targeting of arecombinant singer2chain antigen2binding protein[J]. Natl Cancer Inst,1990,82:1191-1197.
  • 6Yokota T, Milenic DE, WhitlowM, et al. Rapid tumor penetrationof a singer2chain Fv and comparison with other immunoglobulinforms[J]. Cancer Re, 1992,52 : 3402- 3408.
  • 7Schnell R, Vitetta E, Schindler J, et al. Treatment of refractory Hodgkin's lymphoma patientswith an anti2CD25 riein A2chain immu2notoxin [J]. Leukemia, 2000, 14 (13) : 129-135.
  • 8Doronina S O, Toki B E, orgovM Y, et al. Development of potentmonoclonal antibody auristatin conjugates for cancer therapy[J]. Nat Biotechnol, 2003,21 (7): 778-784.

二级参考文献28

  • 1Vogel G. Sequence offers clues to deadly flu[J].Science,1998,16,279(5349):324.
  • 2Luo G,Chung J,Please P.Alteration of the stalk of influenza virus neuraminidase deletions and insertions[J].Virus Ras,1993,29(2):141-153.
  • 3Yasuda J,Bucher D J, Isbihama A. Growth control of influenza A virus by M1 protein anaysis of transfetant viruses carrying the chimeric M gene[J].J Virol,1994,68(2):8141-8146.
  • 4Qiu Y,Krug R M.The influenza virus NS1 protein is a poly(A)-binding protein that inhibits nuclear edport of mRNAs containing poly(A)[J].J Virol,1994,68(4):2425-2432.
  • 5Davis H L,Michel M L.DNA-based immunization induces continuous secretion of hepatitis B surface antigen and high levels of circulating antibody[J].Hum Mol Genet,1993,2(11):1847-1851.
  • 6Webster R G,Laver W G.The origin of pandemic influenza[J].Bull W H O,1972,47:449-452.
  • 7Bean W J,Cox N J,Kendal A P. Recombinations of human influenza A virus in nature[J].Nature,1980,284:638-640.
  • 8Kawaoka Y,Neave C W,Webster R G.Is virulence of H5N2 influenza viruses in chickens associated with loss of carbohydrate from the hemagglutinin[J].Virology,1984,139:303-316.
  • 9Kodihalli S, Kobasa D L,Webster R G.Strategies for inducing protection against avain influenza A virus subtypes with DNA[J].Vaccines,2002,18(23):2592-2599.
  • 10Robinson H L,Hunt L A,Webster R G. Protection against a lethal influenza virus challenge by immunization with a haemagglutinin expressing plasmid DNA [J].Vaccines,1993,11:957-960.

共引文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部